Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

TRACON starts phase I/II TRC-105 trial in prostate cancer

April 28, 2010

FDA clears NexMed's phase II PrevOnco trial in advanced unresectable hepatocellular cancer

April 28, 2010

Cleveland BioLabs opens U.S. office of Incuron to develop anticancer curaxins

April 28, 2010

Cancer cell stemness inhibitor BBI-608 safe and active in ongoing phase I trial

April 28, 2010

Exelixis claims novel mTOR and PI3K-alpha inhibitors

April 28, 2010

Proteo completes patient recruitment in phase II Elafin trial

April 27, 2010

CHMP recommends conditional marketing approval for Votrient

April 27, 2010

Oncolytics Biotech completes phase I enrollment for phase I/II Reolysin trial

April 27, 2010

Temozolomide shows activity in pituitary tumors and carcinomas

April 27, 2010

Telik presents novel Aurora A/B and VEGFR-2 inhibitors

April 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...